Endowing T cells with antibody specificity using chimeric T cell receptors

Area of Science:

• Immunology
• Molecular Biology
• Genetic Engineering

Background:

• T cells recognize peptide-MHC complexes, a process crucial for adaptive immunity.
• Antibodies recognize antigens directly, with simpler binding requirements than T cell receptors (TCRs).
• Structural similarities between antibodies and TCRs suggest potential for functional interchangeability.

Purpose of the Study:

• To engineer T cells with antibody-like antigen specificity using chimeric TCRs (cTCRs).
• To investigate T cell activation, signaling, and the role of MHC molecules.
• To explore potential therapeutic applications of engineered T cells.

Main Methods:

• Construction of chimeric TCR (cTCR) genes by linking antibody variable domains to TCR constant regions.
• Expression of cTCRs in T cells to confer antibody-type specificity.
• Utilizing defined ligands to study cTCR-expressing T cell responses.
• Generation of transgenic mice expressing cTCRs.

Main Results:

• cTCR-expressing T cells exhibit MHC-unrestricted and independent recognition of antigens.
• These engineered T cells demonstrate antibody-like specificity.
• The system allows for the study of physicochemical parameters governing TCR-mediated signaling.
• Transgenic mice facilitate research into MHC's role in T cell development.

Conclusions:

• Chimeric TCR technology enables T cells to recognize antigens with antibody-like specificity, independent of MHC.
• This approach provides a powerful experimental system to dissect T cell activation mechanisms.
• Engineered cTCRs hold promise for targeted cancer and viral immunotherapies.